Other studies, however, suggest that in ERα negative type II endometrial cancer, estrogen continues to stimulate the epithelial mesenchymal transition through the third estrogen receptor, the G-protein coupled estrogen receptor (GPER). Here, ESR1 is linked to endometrial cancer.